Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitlePHASE I STUDY OF BENDAMUSTINE, RITUXIMAB, IBRUTINIB, AND VENETOCLAX IN RELAPSED, REFRACTORY MANTLE CELL LYMPHOMA.AuthorsKumar, A.; Batlevi, C.; Drullinsky, P.; Grieve, C.; Laraque, L.; Joseph, A.; Mahajan, N.; Matasar, M.; Straus, D.; Zelenetz, A.; Hamlin, P.PublicationHematological Oncology, 2021, Vol 39, p1ISSN0278-0232Publication typeArticleDOI10.1002/hon.88_2881